Top123's post 214697 shows why everyone has been way, way too conservative on the value of the B platform. It's uses are so widespread that no current valuation is possible.
To have a product that can be incorporated into textiles, paints, plastics, etc, etc means that B will have an ungodly amount of universal applications not involving patients per se.
Instead of a product that is ingested or aimed at specific patients, it will be incorporated into a plethora of products across a wide spectrum of everyday life for everyone on the planet making all of these products antimicrobial.
Many are reluctant to give a value of the B platform because they will be ridiculed by those with agendas against the company, but IMO B could become one of the largest industrial components in the world in addition to being one of the largest drugs in the world of medicine.
I also believe we will find Kevetrin following a path the likes of B in that it is going to be found to be so compatible with so many other medical products that it will startle everyone.